Home » Topics » Regulatory

Regulatory
RSS

Generic clindamycin approved by FDA

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

Prograf to be submitted in Japan for atopic dermatitis

July 22, 1997

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...